Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice

Behavioural Brain Research

Volumn 183, Issue 2, 2007, Pages 147-155

  Mongeau, Raymond ^a   Marcello, Stefania ^a   Andersen, Jacob Sparre ^c   Pani, Luca ^a,b  

^a SARDEGNA RICERCHE   (Italy)

^b Sezione di Cagliari   (Italy)

^c Tofta Teld   (Denmark)

Author keywords

Antipsychotic drugs; Attention; Benzodiazepine; C57BL 6 mice; Fear conditioning; Negative symptoms; Schizophrenia

Indexed keywords

AMPHETAMINE; ANXIOLYTIC AGENT; CLOZAPINE; DIAZEPAM; DOPAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; EMOTION; FREEZING; HYPERACTIVITY; IMMOBILIZATION STRESS; LATENT INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

AMPHETAMINE; ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMOTIONS; FEAR; FREEZING REACTION, CATALEPTIC; HALOPERIDOL; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, INBRED C57BL; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 34548515267     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.06.002     Document Type: Article

References (39)

1. Benvenga M.J., and Leander J.D. Olanzapine an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology 119 (1995) 133-138
2. Braunstein-Bercovitz H. Is the attentional dysfunction in schizotypy related to anxiety?. Schizophr Res 46 (2002) 255-267
3. Braunstein-Bercovitz H., Dimentman-Ashkenazi I., and Lubow R.E. Stress affects the selection of relevant from irrelevant stimuli. Emotion 1 (2001) 182-192
4. Braunstein-Bercovitz H., Rammsayer T., Gibbons H., and Lubow R.E. Latent inhibition deficits in high-schizotypal normals: symptom-specific or anxiety-related?. Schizophr Res 53 (2002) 109-121
5. Cabib S., and Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl) 128 (1996) 331-342
6. Conrad C.D., Magarinos A.M., LeDoux J.E., and McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dentritic atropy. Behav Neurosci 113 (1999) 902-913
7. Diaz-Otanez C.S., Capriles N.R., and Cancela L.M. D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine. Pharmacol Biochem Behav 58 (1997) 9-14
8. Duncan G.E., Moy S.S., Lieberman J.A., and Koller B.H. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85 (2006) 481-491
9. Feldon J., and Weiner I. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacol Biochem Behav 32 (1989) 123-127
10. Harris J.A., and Westbrook R.F. Contextual control over the expression of fear in rats conditioned under a benzodiazepine. Psychopharmacology (Berl) 156 (2001) 92-97
11. Hellman P.A., Crider A., and Solomon P.R. Interaction of tail-pressure stress and d-amphetamine in disruption of the rat's ability to ignore an irrelevant stimulus. Behav Neurosci 97 (1983) 1017-1021
12. Imperato A., Puglisi-Allegra S., and Cabib S. Repeated stressful experiences differently affect the time-dependent responses of the mesolimbic dopamine system to the stressor. Brain Res 601 (1993) 333-336
13. Imperato A., Obinu M.C., Carta G., Mascia M.S., Casu M.A., and Gessa G.L. Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization. Eur J Pharmacol 317 (1996) 231-237
14. Joseph M.H., Peters S.L., Moran P.M., Grigoryan G.A., Young A.M., and Gray J.A. Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience 101 (2000) 921-930
15. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
16. Lacroix L., Spinelli S., Broersen L.M., and Feldon J. Blockade of latent inhibition following pharmacological increase or decrease of GABA(A) transmission. Pharmacol Biochem Behav 66 (2000) 893-901
17. Lehmann J., Stohr T., and Feldon J. Long-term effects of prenatal stress experiences and postnatal maternal separation on emotionality and attentional processes. Behav Brain Res 107 (2000) 133-144
18. Levin E.D., Petro A., and Beatty A. Olanzapine interactions with nicotine and mecamylamine in rats: effects on memory function. Neurotoxicol Teratol 27 (2005) 459-464
19. Leyton M., and Stewart J. Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus accumbens amphetamine. Pharmacol Biochem Behav 37 (1990) 303-310
20. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull 31 (2005) 139-153
21. McDonald L.M., Moran P.M., Vythelingum G.N., Joseph M.H., Stephenson J.D., and Gray J.A. Latent inhibition is attenuated by noise and partially restored by a 5-HT2A receptor antagonist. Behav Pharmacol 13 (2002) 663-667
22. McGaughy J., and Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117 (1995) 340-357
23. Melo L.L., Ferrari E.A., Teixeira N.A., and Sandner G. Enhancement of latent inhibition by chronic mild stress in rats submitted to emotional response conditioning. Neural Plast 10 (2003) 327-333
24. Mongeau R., Miller G.A., Chiang E., and Anderson D.J. Neural correlates of competing fear behaviors evoked by an innately aversive stimulus. J Neurosci 23 (2003) 3855-3868
25. Moore N.A., Tye N.C., Axton M.S., and Risius F.C. The behavioral pharmacology of olanzapine, a novel atypical antipsychotic agent. J Pharmacol Exp Ther 262 (1992) 545-551
26. Murphy C.A., Heidbreder C., and Feldon J. Acute withdrawal from repeated cocaine treatment enhances latent inhibition of a conditioned fear response. Behav Pharmacol 12 (2001) 13-23
27. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006) 546-554
28. Restivo L., Passino E., Middei S., and Ammassari-Teule M. The strain-specific involvement of nucleus accumbens in latent inhibition might depend on differences in processing configural- and cue-based information between C57BL/6 and DBA mice. Brain Res Bull 57 (2002) 35-39
29. Rex A., Voigt J.P., Voits M., and Fink H. Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs. Pharmacol Biochem Behav 59 (1998) 677-683
30. Rodriguez Manzanares P.A., Isoardi N.A., Carrer H.F., and Molina V.A. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J Neurosci 25 (2005) 8725-8734
31. Shadach E., Gaisler I., Schiller D., and Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology 23 (2000) 151-161
32. Shalev U., Feldon J., and Weiner I. Latent inhibition is disrupted by acute and repeated administration of corticosterone. Int J Neuropsychopharmcol 1 (1998) 103-113
33. Shalev U., and Weiner I. Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behav Brain Res 126 (2001) 57-63
34. Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology (Berl) 124 (1996) 126-133
35. Thiebot M.H. Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9 (1985) 95-100
36. Ventura R., Puglisi-Allegra S., and Cabib S. Opposite genotype-dependent mesocorticolimbic dopamine response to stress. Neuroscience 104 (2001) 627-631
37. Ventura R., Puglisi-Allegra S., and Cabib S. Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression. Neuroscience 115 (2002) 999-1007
38. Weiner I., Schiller D., and Gaisler-Salomon I. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology 28 (2003) 499-509
39. Wheeler D.S., Chang R.C., and Miller R.R. Massive preexposure and preexposure in multiple contexts attenuate the context specificity of latent inhibition. Learn Behav 31 (2003) 378-386